Koyfin Home > Directory > Health Care > Amphastar Pharma > Cash from Investing Activities

Amphastar Pharma Cash from Investing Activities Chart (AMPH)

Amphastar Pharma annual/quarterly Cash from Investing Activities from 2014 to 2018.
  • Amphastar Pharma Cash from Investing Activities for the quarter ending September 09, 2018 was $-13m a 21.33% decrease of -3m year over year
  • Amphastar Pharma Cash from Investing Activities for the last 12 months ending September 09, 2018 was $-45m a 14.60% decrease of -7m year over year
  • Amphastar Pharma Annual Cash from Investing Activities for 2017 was $-39m a -1.92% increase of 1m from 2016
  • Amphastar Pharma Annual Cash from Investing Activities for 2016 was $-40m a 57.15% decrease of -23m from 2015
  • Amphastar Pharma Annual Cash from Investing Activities for 2015 was $-17m a -135.00% increase of 23m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Cash from Investing Activities Data

09/2018$-13m
06/2018$-12m
03/2018$-9m
12/2017$-10m
09/2017$-13m
06/2017$-8m
03/2017$-6m
12/2016$-7m
09/2016$-15m
06/2016$-8m

Annual AMPH Cash from Investing Activities Data

2017$-39m
2016$-40m
2015$-17m
2014$-40m
2013$-18m